14 insiders reported 64 Form 4 transactions for Tango Therapeutics, Inc. (TNGX) over the past 18 months (most recent 2026-08-05). Recent activity: Crystal Adam (President, R&D) Sell 5,267 shares, Crystal Adam (President, R&D) Sell 21,733 shares, Crystal Adam (President, R&D) Buy 27,000 shares, Crystal Adam (President, R&D) Sell 7,371 shares, Crystal Adam (President, R&D) Buy 27,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-05 | Crystal Adam | President, R&D | Sell | 5,267 | $141,100 |
| 2026-08-05 | Crystal Adam | President, R&D | Sell | 21,733 | $594,417 |
| 2026-08-05 | Crystal Adam | President, R&D | Buy | 27,000 | $140,400 |
| 2026-07-02 | Crystal Adam | President, R&D | Sell | 7,371 | $222,946 |
| 2026-07-02 | Crystal Adam | President, R&D | Buy | 27,000 | $140,400 |
| 2026-07-02 | Crystal Adam | President, R&D | Sell | 19,629 | $575,962 |
| 2026-06-23 | Azelby Robert | Director | Buy | 5,740 | $0 |
| 2026-06-08 | Calhoun Lesley Ann | Director | Buy | 4,000 | $0 |
| 2026-06-08 | Lee Sung | Director | Buy | 570 | $0 |
| 2026-06-08 | Rothenberg Mace | Director | Buy | 4,000 | $0 |
| 2026-06-08 | Ketchum John B | Director | Buy | 4,000 | $0 |
| 2026-06-03 | Crystal Adam | President, R&D | Sell | 6,140 | $136,627 |
| 2026-06-03 | Crystal Adam | President, R&D | Buy | 27,000 | $140,400 |
| 2026-06-03 | Crystal Adam | President, R&D | Sell | 20,860 | $480,944 |
| 2026-05-05 | Gall Matthew | Chief Financial Officer | Buy | 40,000 | $0 |
| 2026-05-05 | Crystal Adam | President, R&D | Buy | 27,000 | $140,400 |
| 2026-05-05 | Crystal Adam | President, R&D | Sell | 25,900 | $548,901 |
| 2026-05-05 | Crystal Adam | President, R&D | Sell | 1,100 | $24,196 |
| 2026-05-01 | Lee Sung | Director | Buy | 12,300 | $0 |
| 2026-04-16 | Crystal Adam | President, R&D | Buy | 38,460 | $199,992 |
| 2026-04-16 | Crystal Adam | President, R&D | Sell | 38,460 | $961,500 |
| 2026-04-02 | Crystal Adam | President, R&D | Buy | 27,000 | $140,400 |
| 2026-04-02 | Crystal Adam | President, R&D | Sell | 27,000 | $572,478 |
| 2026-03-27 | Crystal Adam | President, R&D | Buy | 12,000 | $62,400 |
| 2026-03-27 | Crystal Adam | President, R&D | Sell | 12,000 | $241,320 |
Source: SEC Form 4 filings · as of 2026-08-05